PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35328215-11	2022	Noteworthy are BRAF and RET/PTC alterations already validated as targets of Dabrafenib-mesylate, Pralsetinib and Selpercatinib.	Dabrafenib mesylate	76-95	ret proto-oncogene	Homo sapiens	24-27	
35328215-11	2022	Noteworthy are BRAF and RET/PTC alterations already validated as targets of Dabrafenib-mesylate, Pralsetinib and Selpercatinib.	Dabrafenib mesylate	76-95	ret proto-oncogene	Homo sapiens	28-31